From HandWiki - Reading time: 5 min
| Error creating thumbnail: Unable to save thumbnail to destination | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C19H27N3O |
| Molar mass | 313.445 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
MEPIRAPIM is an indole-based cannabinoid which differs from JWH-018 by having a 4-methylpiperazine group in place of the naphthyl group[1] and has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in 2013, alongside FUBIMINA.[2] MEPIRAPIM acts as a T-type calcium channelinhibitor and is only minimally active at the central CB1 receptor.[3]
Sweden's public health agency suggested to classify MEPIRAPIM as hazardous substance on November 10, 2014.[4]